Antimigratory effects of the methanol extract from momordica charantia on human lung adenocarcinoma CL1 cells

Evidence-based Complementary and Alternative Medicine

Volumn 2012, Issue , 2012, Pages

  Hsu, Hsue Yin ^a   Lin, Jung Hsuan ^a   Li, Chia Jung ^a   Tsang, Shih Fang ^a   Tsai, Chun Hao ^a   Chyuan, Jong Ho ^b   Chiu, Shu Jun ^a   Chuang, Shuang En ^c  

^a TZU CHI UNIVERSITY   (Taiwan)

^b Hualien District Agricultural Research and Extension Station   (Taiwan)

^c NATIONAL HEALTH RESEARCH INSTITUTES   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

BETA CATENIN; FOCAL ADHESION KINASE; GELATINASE A; GELATINASE B; MATRIX METALLOPROTEINASE; METHANOL; METHANOL EXTRACT OF MOMORDICA CHARANTIA; MOMORDICA CHARANTIA EXTRACT; PROTEIN KINASE B; PROTEIN TYROSINE KINASE; UNCLASSIFIED DRUG; WNT2 PROTEIN;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CARCINOMA CELL; CELL INVASION; CELL MIGRATION; CELL VIABILITY; CONTROLLED STUDY; CYTOTOXICITY; DRUG EFFICACY; ENZYME ACTIVITY; ENZYME LINKED IMMUNOSORBENT ASSAY; GROWTH INHIBITION; HUMAN; HUMAN CELL; LUNG ADENOCARCINOMA; MEDIATOR; METASTASIS; MOMORDICA CHARANTIA; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECEPTOR UPREGULATION; SIGNAL TRANSDUCTION; TUMOR CELL LINE; WESTERN BLOTTING;

EID: 84872138701     PISSN: 1741427X     EISSN: 17414288     Source Type: Journal    
DOI: 10.1155/2012/819632     Document Type: Article

References (53)

1. Meng F., Ma L., Progression in therapy of erlotinib for patients with non-small cell lung cancer. Chinese Journal of Lung Cancer 2009 12 12 1352 1355
2. Fong K. M., Sekido Y., Minna J. D., Molecular pathogenesis of lung cancer. The Journal of Thoracic and Cardiovascular Surgery 1999 118 6 1136 1152 10.1016/S0022-5223(99)70121-2
3. Cance W. G., Harris J. E., Iacocca M. V., Roche E., Yang X. H., Chang J., Simkins S., Xu L. H., Immunohistochemical analyses of focal adhesion kinase expression in benign and malignant human breast and colon tissues: correlation with preinvasive and invasive phenotypes. Clinical Cancer Research 2000 6 6 2417 2423 2-s2.0-0034044795 (Pubitemid 30399210)
4. Hauck C. R., Sieg D. J., Hsia D. A., Loftus J. C., Gaarde W. A., Monia B. P., Schlaepfer D. D., Inhibition of focal adhesion kinase expression or activity disrupts epidermal growth factor-stimulated signaling promoting the migration of invasive human carcinoma cells. Cancer Research 2001 61 19 7079 7090 2-s2.0-0035476836 (Pubitemid 32946499)
5. Hauck C. R., Hsia D. A., Puente X. S., Cheresh D. A., Schlaepfer D. D., FRNK blocks v-Src-stimulated invasion and experimental metastases without effects on cell motility or growth. The EMBO Journal 2002 21 23 6289 6302 2-s2.0-0037011055 10.1093/emboj/cdf631 (Pubitemid 35448407)
6. Shen J., Xu L., Owonikoko T. K., Sun S. Y., Khuri F. R., Curran W. J., Deng X., NNK promotes migration and invasion of lung cancer cells through activation of c-Src/PKCiota/FAK loop. Cancer Letters 2012 318 1 106 113 10.1016/j.canlet.2011.12.008
7. Verbeek B. S., Vroom T. M., Rijksen G., Overexpression of c-Src enhances cell-matrix adhesion and cell migration in PDGF-stimulated NIH3T3 fibroblasts. Experimental Cell Research 1999 248 2 531 537 2-s2.0-0033134019 10.1006/excr.1999.4416 (Pubitemid 29394812)
8. Schlaepfer D. D., Mitra S. K., Multiple connections link FAK to cell motility and invasion. Current Opinion in Genetics & Development 2004 14 1 92 101 10.1016/j.gde.2003.12.002 (Pubitemid 38167483)
9. Xu X. M., Zhang Y., Qu D., Feng X. W., Chen Y., Zhao L., Osthole suppresses migration and invasion of A549 human lung cancer cells through inhibition of matrix metalloproteinase-2 and matrix metallopeptidase-9 in vitro. Molecular Medicine Reports 2012 6 5 1018 1022
10. Bienz M., Clevers H., Linking colorectal cancer to Wnt signaling. Cell 2000 103 2 311 320 10.1016/S0092-8674(00)00122-7
11. You L., He B., Xu Z., Uematsu K., Mazieres J., Mikami I., Reguart N., Moody T. W., Kitajewski J., McCormick F., Jablons D. M., Inhibition of Wnt-2-mediated signaling induces programmed cell death in non-small-cell lung cancer cells. Oncogene 2004 23 36 6170 6174 2-s2.0-4344570800 10.1038/sj.onc.1207844 (Pubitemid 39178870)
12. Nelson W. J., Nusse R., Convergence of Wnt, beta-catenin, and cadherin pathways. Science 2004 303 5663 1483 1487 10.1126/science.1094291 (Pubitemid 38314410)
13. Cadigan K. M., Wnt-beta-catenin signaling. Current Biology 2008 18 20 R943 R947 10.1016/j.cub.2008.08.017
14. Chu Y. W., Yang P. C., Yang S. C., Shyu Y. C., Hendrix M. J. C., Wu R., Wu C. W., Selection of invasive and metastatic subpopulations from a human lung adenocarcinoma cell line. American Journal of Respiratory Cell and Molecular Biology 1997 17 3 353 360 2-s2.0-0031226737 (Pubitemid 127500840)
15. Tan M. J., Ye J. M., Turner N., Hohnen-Behrens C., Ke C. Q., Tang C. P., Chen T., Weiss H. C., Gesing E. R., Rowland A., James D. E., Ye Y., Antidiabetic activities of triterpenoids isolated from bitter melon associated with activation of the AMPK pathway. Chemistry and Biology 2008 15 3 263 273 2-s2.0-40749137409 10.1016/j.chembiol.2008.01.013 (Pubitemid 351381992)
16. Lee-Huang S., Huang P. L., Bourinbaiar A. S., Chen H. C., Kung H. F., Inhibition of the integrase of human immunodeficiency virus (HIV) type 1 by anti-HIV plant proteins MAP30 and GAP31. Proceedings of the National Academy of Sciences of the United States of America 1995 92 19 8818 8822 2-s2.0-0028981211 10.1073/pnas.92.19.8818
17. Das P., Sinhababu S. P., Dam T., Screening of antihelminthic effects of Indian plant extracts: a preliminary report. Journal of Alternative and Complementary Medicine 2006 12 3 299 301 2-s2.0-33646465676 10.1089/acm.2006.12. 299
18. Schreiber C. A., Wan L., Sun Y., Lu L., Krey L. C., Lee-Huang S., The antiviral agents, MAP30 and GAP31, are not toxic to human spermatozoa and may be useful in preventing the sexual transmission of human immunodeficiency virus type 1. Fertility and Sterility 1999 72 4 686 690 2-s2.0-0033215271 10.1016/S0015-0282(99)00302-7 (Pubitemid 29475131)
19. Ray R. B., Raychoudhuri A., Steele R., Nerurkar P., Bitter melon (Momordica charantia) extract inhibits breast cancer cell proliferation by modulating cell cycle regulatory genes and promotes apoptosis. Cancer Research 2010 70 5 1925 1931 2-s2.0-77950278220 10.1158/0008-5472.CAN-09-3438
20. Limtrakul P., Khantamat O., Pintha K., Inhibition of P-glycoprotein activity and reversal of cancer multidrug resistance by Momordica charantia extract. Cancer Chemotherapy and Pharmacology 2004 54 6 525 530 2-s2.0-11144323815 10.1007/s00280-004-0848-4 (Pubitemid 40022248)
21. Pitchakarn P., Ogawa K., Suzuki S., Takahashi S., Asamoto M., Chewonarin T., Limtrakul P., Shirai T., Momordica charantia leaf extract suppresses rat prostate cancer progression in vitro and in vivo. Cancer Science 2010 101 10 2234 2240 2-s2.0-77957037371 10.1111/j.1349-7006.2010.01669.x
22. Wang L., Cai Y., Zhang X. Q., Fan C. L., Zhang Q. W., Lai X. P., Ye W. C., New triterpenoid glycosides from the roots of Ilex asprella. Carbohydrate Research 2012 349 39 43 10.1016/j.carres.2011.12.003
23. Lee-Huang S., Huang P. L., Chen H. C., Huang P. L., Bourinbaiar A., Huang H. I., Kung H. F., Anti-HIV and anti-tumor activities of recombinant MAP30 from bitter melon. Gene 1995 161 2 151 156 2-s2.0-0029135318 10.1016/0378-1119(95) 00186-A
24. Lee-Huang S., Huang P. L., Sun Y., Chen H. C., Kung H. F., Huang P. L., Murphy W. J., Inhibition of MDA-MB-231 human breast tumor xenografts and HER2 expression by anti-tumor agents GAP31 and MAP30. Anticancer Research 2000 20 2 653 659 2-s2.0-0034090956 (Pubitemid 30240615)
25. Li C. J., Tsang S. F., Tsai C. H., Tsai H. Y., Chyuan J. H., Hsu H. Y., Momordica charantia extract induces apoptosis in human cancer cells through caspase- and mitochondria-dependent pathways. Evidence-Based Complementary and Alternative Medicine 2012 2012 11 261971 10.1155/2012/261971
26. Cross D. A. E., Alessi D. R., Cohen P., Andjelkovich M., Hemmings B. A., Inhibition of glycogen synthase kinase-3 by insulin mediated by protein kinase B. Nature 1995 378 6559 785 789 2-s2.0-0029587224 10.1038/378785a0 (Pubitemid 26004411)
27. Satelli A., Li S., Vimentin in cancer and its potential as a molecular target for cancer therapy. Cellular and Molecular Life Sciences 2011 68 18 3033 3046 2-s2.0-79957644383 10.1007/s00018-011-0735-1
28. Gupta G. P., Massagué J., Cancer metastasis: building a framework. Cell 2006 127 4 679 695 2-s2.0-33751252276 10.1016/j.cell.2006.11.001 (Pubitemid 44781029)
29. Sakurai H., Maeshima A., Watanabe S. I., Suzuki K., Tsuchiya R., Maeshima A. M., Matsuno Y., Asamura H., Grade of stromal invasion in small adenocarcinoma of the lung: histopathological minimal invasion and prognosis. American Journal of Surgical Pathology 2004 28 2 198 206 2-s2.0-1642453628 10.1097/00000478-200402000-00007 (Pubitemid 38124728)
30. Shieh J. M., Cheng T. H., Shi M. D., Wu P. F., Chen Y., Ko S. C., Shih Y. W., Alpha-tomatine suppresses invasion and migration of human non-small cell lung cancer NCI-H460 cells through inactivating FAK/PI3K/Akt signaling pathway and reducing binding activity of NF-kappaB. Cell Biochemistry and Biophysics 2011 60 3 297 310 2-s2.0-79958281788 10.1007/s12013-011-9152-1
31. Zhao X., Guan J. L., Focal adhesion kinase and its signaling pathways in cell migration and angiogenesis. Advanced Drug Delivery Reviews 2011 63 8 610 615 2-s2.0-79959971564 10.1016/j.addr.2010.11.001
32. Mitra S. K., Hanson D. A., Schlaepfer D. D., Focal adhesion kinase: in command and control of cell motility. Nature Reviews Molecular Cell Biology 2005 6 1 56 68 2-s2.0-11244258882 10.1038/nrm1549 (Pubitemid 40064899)
33. Shibata K., Kikkawa F., Nawa A., Thant A. A., Naruse K., Mizutani S., Hamaguchi M., Both focal adhesion kinase and c-Ras are required for the enhanced matrix metalloproteinase 9 secretion by fibronectin in ovarian cancer cells. Cancer Research 1998 58 5 900 903 2-s2.0-0032031062 (Pubitemid 28182455)
34. Slack-Davis J. K., Martin K. H., Tilghman R. W., Iwanicki M., Ung E. J., Autry C., Luzzio M. J., Cooper B., Kath J. C., Roberts W. G., Parsons J. T., Cellular characterization of a novel focal adhesion kinase inhibitor. The Journal of Biological Chemistry 2007 282 20 14845 14852 2-s2.0-34447538483 10.1074/jbc.M606695200 (Pubitemid 47093369)
35. Eliceiri B. P., Puente X. S., Hood J. D., Stupack D. G., Schlaepfer D. D., Huang X. Z., Sheppard D., Cheresh D. A., Src-mediated coupling of focal adhesion kinase to integrin α v β 5 in vascular endothelial growth factor signaling. Journal of Cell Biology 2002 157 1 149 160 2-s2.0-0036544562 10.1083/jcb.200109079 (Pubitemid 34847837)
36. Roberts W. G., Ung E., Whalen P., Cooper B., Hulford C., Autry C., Richter D., Emerson E., Lin J., Kath J., Coleman K., Yao L., Martinez-Alsina L., Lorenzen M., Berliner M., Luzzio M., Patel N., Schmitt E., LaGreca S., Jani J., Wessel M., Marr E., Griffor M., Vajdos F., Antitumor activity and pharmacology of a selective focal adhesion kinase inhibitor, PF-562,271. Cancer Research 2008 68 6 1935 1944 2-s2.0-40949152523 10.1158/0008-5472.CAN-07-5155 (Pubitemid 351416580)
37. Iiizumi M., Liu W., Pai S. K., Furuta E., Watabe K., Drug development against metastasis-related genes and their pathways: a rationale for cancer therapy. Biochimica et Biophysica Acta 2008 1786 2 87 104 2-s2.0-56049111865 10.1016/j.bbcan.2008.07.002
38. Sienel W., Hellers J., Morresi-Hauf A., Lichtinghagen R., Mutschler W., Jochum M., Klein C., Passlick B., Pantel K., Prognostic impact of matrix metalloproteinase-9 in operable non-small cell lung cancer. International Journal of Cancer 2003 103 5 647 651 2-s2.0-0037455842 10.1002/ijc.10841 (Pubitemid 36091469)
39. Passlick B., Sienel W., Seen-Hibler R., Wockel W., Thetter O., Mutschler W., Pantel K., Overexpression of matrix metalloproteinase 2 predicts unfavorable outcome in early-stage non-small cell lung cancer. Clinical Cancer Research 2000 6 10 3944 3948 2-s2.0-0033760493
40. Cantley L. C., The phosphoinositide 3-kinase pathway. Science 2002 296 5573 1655 1657 2-s2.0-0037205048 10.1126/science.296.5573.1655 (Pubitemid 34579158)
41. Brugge J., Hung M. C., Mills G. B., A new mutational aktivation in the PI3K pathway. Cancer Cell 2007 12 2 104 107 2-s2.0-34547574720 10.1016/j.ccr.2007.07.014 (Pubitemid 47199129)
42. Rychahou P. G., Kang J., Gulhati P., Doan H. Q., Chen L. A., Xiao S. Y., Chung D. H., Evers B. M., Akt2 overexpression plays a critical role in the establishment of colorectal cancer metastasis. Proceedings of the National Academy of Sciences of the United States of America 2008 105 51 20315 20320 2-s2.0-58149503692 10.1073/pnas.0810715105
43. Dahlhoff M., Siegmund A., Golub Y., Wolf E., Holsboer F., Wotjak C. T., AKT/GSK-3 β / β -catenin signalling within hippocampus and amygdala reflects genetically determined differences in posttraumatic stress disorder like symptoms. Neuroscience 2010 169 3 1216 1226 2-s2.0-77955275222 10.1016/j.neuroscience.2010.05.066
44. Qiang Y. W., Walsh K., Yao L., Kedei N., Blumberg P. M., Rubin J. S., Shaughnessy J., Rudikoff S., Wnts induce migration and invasion of myeloma plasma cells. Blood 2005 106 5 1786 1793 2-s2.0-23944524848 10.1182/blood-2005- 01-0049 (Pubitemid 41208595)
45. Bienz M., β -catenin: a pivot between cell adhesion and Wnt signalling. Current Biology 2005 15 2 R64 R67 2-s2.0-12544252343 10.1016/j.cub.2004.12.058
46. Song Y., Yang Q. X., Zhang F., Meng F., Li H., Dong Y., Han A., Suppression of nasopharyngeal carcinoma cell by targeting beta-catenin signaling pathway. Cancer Epidemiology 2012 36 2 e116 e121 10.1016/j.canep.2011.11.002
47. Gwak J., Lee J. H., Chung Y. H., Song G. Y., Oh S., Small molecule-based promotion of PKCalpha-mediated beta-catenin degradation suppresses the proliferation of CRT-positive cancer cells. PLOS ONE 2012 7 10 e46697
48. Nakashima T., Liu D., Nakano J., Ishikawa S., Yokomise H., Ueno M., Kadota K., Huang C. L., Wnt1 overexpression associated with tumor proliferation and a poor prognosis in non-small cell lung cancer patients. Oncology Reports 2008 19 1 203 209 2-s2.0-38749108492 (Pubitemid 351176150)
49. Kausar H., Jeyabalan J., Aqil F., Chabba D., Sidana J., Singh I. P., Gupta R. C., Berry anthocyanidins synergistically suppress growth and invasive potential of human non-small-cell lung cancer cells. Cancer Letters 2012 325 1 54 62 10.1016/j.canlet.2012.05.029
50. Kim N. G., Xu C., Gumbiner B. M., Identification of targets of the Wnt pathway destruction complex in addition to β -catenin. Proceedings of the National Academy of Sciences of the United States of America 2009 106 13 5165 5170 2-s2.0-65249128611 10.1073/pnas.0810185106
51. Veeman M. T., Axelrod J. D., Moon R. T., A second canon: functions and mechanisms of β -catenin-independent Wnt signaling. Developmental Cell 2003 5 3 367 377 2-s2.0-0041695485 10.1016/S1534-5807(03)00266-1 (Pubitemid 37107667)
52. Yook J. I., Li X. Y., Ota I., Fearon E. R., Weiss S. J., Wnt-dependent regulation of the E-cadherin repressor snail. The Journal of Biological Chemistry 2005 280 12 11740 11748 2-s2.0-15744374449 10.1074/jbc.M413878200 (Pubitemid 40418488)
53. Fuentealba L. C., Eivers E., Ikeda A., Hurtado C., Kuroda H., Pera E. M., De Robertis E. M., Integrating patterning signals: Wnt/GSK3 regulates the duration of the BMP/Smad1 signal. Cell 2007 131 5 980 993 2-s2.0-36248995245 10.1016/j.cell.2007.09.027 (Pubitemid 350138081)